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Abstract  
Purpose: To test whether or not one out of two membranes is superior for peri-
implant guided bone regeneration in terms of clinical and histologic outcomes.  
Materials and Methods: In 27 patients, 27 two-piece dental implants were 
placed in single-tooth gaps in the esthetic area. Buccal dehiscence and/or 
fenestration-type defects were regenerated using demineralized bovine bone 
mineral (DBBM) and randomly covered with either a resorbable membrane (RES) 
or a titanium-reinforced non-resorbable membrane (N-RES). Clinical 
measurements included vertical defect resolution and the horizontal thickness of 
regenerated bone at implant placement and at 6 months. Statistics were 
performed by means of non-parametric testing. 
Results: The remaining mean vertical defect measured 4.00mm (±2.07) (RES) 
and 2.36mm (±2.09) (N-RES) (p=0.044) at baseline and 0.77mm (±0.85) (RES) 
and 0.21mm (±0.80) (N-RES) (p=0.021) at re-entry. This translated into a 
defect resolution of 85% (RES) and 90.7% (N-RES) (p=0.10). The horizontal 
thickness after augmentation measured 3.46mm (±0.52) (RES) and 2.82mm 
(±0.50) (N-RES) (p=0.004). The mean loss in horizontal thickness from baseline 
to re-entry measured 2.23mm (SD±1.21) (RES) and 0.14mm (±0.79) (N-RES) 
(p=0.017). The horizontal changes in thickness at the implant shoulder level 
were statistically significant between the groups (p=0.0001).  
Conclusions: Both treatment modalities were clinically effective in regenerating 
bone as demonstrated by a similar horizontal thickness and vertical defect fill at 6 
months. The N-RES group exhibited significantly less horizontal bone thickness 
reduction from baseline to follow-up. 
Introduction 
Guided bone regeneration (GBR) procedures are routinely performed in dental 
practice to regenerate missing hard tissue volume prior to or simultaneously with 
dental implant placement (Hammerle et al., 2002, Bornstein et al., 2008, 
Hammerle and Karring, 1998). Various GBR techniques have been proposed and 
numerous materials are available to the practitioner (Donos et al., 2008, Esposito 
et al., 2006, Aghaloo and Moy, 2007, Jensen and Terheyden, 2009, Benic and 
Hammerle, 2014).  
Initially, the GBR technique was developed to regenerate periodontal tissues 
(Nyman et al., 1982, Gottlow et al., 1984, Gottlow et al., 1986). Later, this 
technique was also suggested and applied for bone augmentation around dental 
implants (Jovanovic et al., 1992, Karring et al., 1993). For that purpose 
autogenous bone or bone substitute materials in combination with non-resorbable 
barrier membranes were used. The integration of titanium reinforcements into 
non-resorbable expanded polytetrafluorethylene (ePTFE) membranes increased 
their stability and allowed the membrane to be formed into an adequate shape. 
Despite high clinical success rates (Friedmann et al., 2001, von Arx et al., 2001, 
Buser et al., 2002), ePTFE membranes exhibit two main clinical disadvantages: i) 
an additional surgery procedure is necessary to remove the membrane; ii) 
increased rates of membrane exposure leading to impaired wound healing, 
especially during the early healing phase (Piette et al., 1995, Moses et al., 2005) 
and, bacterial colonization with subsequent infection of the augmented site 
(Becker et al., 1994, Simion et al., 1994, Strietzel, 2001). 
In order to overcome these shortcomings, resorbable membranes were 
introduced. Among these, collagen membranes are well documented and render 
high clinical success rates (Pitaru et al., 1987, Zitzmann et al., 1997, Hockers et 
al., 1999, Zitzmann et al., 2001a, Friedmann et al., 2001, Hammerle and Lang, 
2001, Hammerle et al., 1998). However, these relatively soft membranes do not 
maintain space per se and a compression of the regenerated site can potentially 
result in a displacement of the augmentation material (Strietzel et al., 2006, 
Friedmann et al., 2002) 
 
 
 
To date, there is weak evidence with respect to the morphological changes of the 
augmented tissues following GBR procedures around dental implants. A variety of 
studies focused on the stability of the mucosal margin (Jemt et al., 2006, Priest, 
2003, Grunder, 2000) and the height of the papilla around implant-supported 
crowns (Cardaropoli et al., 2006, Chang et al., 1999). However, the changes of 
contour and morphology of the labial peri-implant tissues have not been 
investigated in detail (Jemt et al., 2006, Jemt and Lekholm, 2003) until recently 
(Jensen et al., 2014, Schneider et al., 2014). 
The aim of the present study was to test whether or not one of two GBR 
membranes is superior to the other in terms of: i) vertical defect resolution and 
bucco-oral width of regenerated bone at the implant shoulder at 6 months ii) 
postoperative complications during the 6-month follow-up and, iii) histologically 
assessed mineralized tissue at 6 months.  
 
Materials and methods 
This study was designed as a prospective randomized controlled clinical trial. All 
procedures and materials were approved by the local ethical committee (Nr. 
2010-0051/5). Twenty-seven patients with a single tooth gap (central incisor to 
premolar in the maxilla or mandible) in need of implant treatment were 
consecutively recruited at the Clinic of Fixed and Removable Prosthodontics and 
Dental Material Science, Center of Dental Medicine, the University of Zurich, 
Switzerland. Informed consent was obtained from all patients prior to the start of 
the study. The following inclusion criteria were applied: 
1. Periodontally healthy patients (periodontal probing depths <4mm) 
2. Good oral hygiene (full mouth plaque index <25%) (O'Leary et al., 1972) 
3. Adequate control of inflammation (full mouth bleeding on probing <25% 
(Ainamo and Bay, 1975) 
4. Single tooth gaps with a buccal alveolar bone deficiency 
5. Planned implant placement >6 weeks after tooth extraction  
6. A dehiscence or fenestration-type defect after implant placement  
Patients not meeting all inclusion criteria were not enrolled prior to surgery (1-5) 
or excluded from the study after implant placement (6). 
Enrolled patients were scheduled for a baseline visit. This examination 
encompassed the following assessments: clinical periodontal parameters 
(periodontal probing depth (PPD), plaque control record (PCR), bleeding on 
probing (BOP), all at six sites around the adjacent teeth; the width of keratinized 
tissue (KM) on the buccal side of the two neighboring teeth, a conventional 
impression (President, Coltène/Whaledent, Altstätten, Switzerland) and clinical 
photographs of the planned implant site. Two to 4 weeks after the baseline visit, 
implant surgery was performed.  
 
 
Surgical protocol 
Prior to the start of the surgery, patients had to rinse with a 0.2% Chlorhexidine 
solution for one minute and were given antibiotics (Amoxicillin 750mg, Sandoz 
Pharmaceuticals, Risch, Switzerland) and analgesics (Mefenacid 500mg, Mepha 
Pharma AG, Basel, Switzerland). Local anesthesia was achieved with Articaine 
hydrochloride (Rudocaine forte®, Streuli, Switzerland). Following an intrasulcular 
incision around the two neighbouring teeth and a vertical releasing incision at the 
disto-buccal aspect of the distal neighboring tooth a mucoperiosteal flap was 
raised. The implant site was prepared according to the manufacturers 
recommendations and a screw type, rough surface two-piece dental implant 
(OsseoSpeed, ASTRA TECH Implant System, DENTSPLY Implants, Mölndal, 
Sweden) was placed in a prosthetically ideal position using a surgical stent. 
Implants had to reach primary stability. Subsequently, the peri-implant osseous 
defect was measured using a calibrated periodontal probe (PCP-11, Hu-Friedy, 
Chicago, USA). Clinical measurements included defect height, depth, width and 
infrabony defect size (Fig.1). If no bone defect was present and no bone 
augmentation was needed, the patient was excluded from the study. 
Simultaneous GBR was performed using demineralized bovine bone mineral 
(DBBM, BioOss spongiosa granules, particle size 0.25-1.0mm; Geistlich Pharma 
AG, Wolhusen, Switzerland). At this time-point according to a computer-
generated randomization list and using sealed envelopes (prepared by the study 
monitor), either one of two membranes was applied:   
i) resorbable collagen membrane (BioGide, Geistlich Pharma AG, 
Wolhusen, Switzerland) (RES) 
ii) non-resorbable ePTFE-membrane (Gore-Tex®, W.L. Gore & Assoc., 
Flagstaff, Arizona, USA) (N-RES) 
 
The peri-implant defect and the missing hard tissue contour were built up with 
DBBM particles. The horizontally augmented thickness on the buccal side was 
measured at the level of the implant shoulder (Fig.1). In group RES, the 
resorbable membrane was cut to fit the osseous defect covering the respective 
bone regenerate. Two to three resorbable pins made of polylactic acid (Inion 
Pins; Geistlich AG, Wolhusen, Switzerland) were then used to tack the 
membrane buccally onto the underlying bone to avoid membrane and DBBM 
displacement. In group N-RES, the ePTFE-membrane was extraorally shaped and 
adapted to fit the defect size. Non-resorbable titanium pins (Frios®, Friadent 
GmbH, Mannheim, Germany) were used to stabilize the membrane. Both 
membranes had to overlap the borders of the augmented site defect by at least 
2mm. On the palatal/lingual aspect the membranes were placed under the flap. 
Subsequently, releasing incisions within the periosteum were performed on the 
buccal aspect of the flap to allow for a tension-free wound closure. Primary 
wound closure was obtained using non-resorbable sutures (Gore-Tex suture; 
Gore, Flagstaff, AZ, USA).  
The patients were then instructed to refrain from mechanical plaque removal in 
the surgical area for 7-10 days and had to follow a strict postoperative regimen. 
This consisted of rinsing with an aqueous solution of 0.2% chlorhexidine 
(Kantonsapotheke, Zurich, Switzerland), of a medication with antibiotics for 5 
days (Amoxicillin 750mg, Sandoz Pharmaceuticals, Risch, Switzerland) and 
analgesics (Mefenacid 500mg, Mepha Pharma AG, Basel, Switzerland) according 
to individual needs. 
 
Follow-up visits  
Suture removal was performed 7-10 days after implant placement. Patients were 
then recalled at 4 weeks, at 3 and at 6 months to assess the soft tissue condition 
(normal, swollen, red, dehiscence). In addition, a conventional impression 
(President, Coltène/Whaledent, Altsätten, Switzerland) and clinical photographs 
of the implant sites were taken at each time-point. At 6 months, re-entry surgery 
was performed in all patients by elevating a full thickness flap to again measure 
the vertical defect fill and the horizontal thickness of the bone at the buccal 
aspect of the implant with a calibrated periodontal probe (PCP-11, Hu-Friedy, 
Chicago, USA). These measurements were performed at the level of the implant 
shoulder. In addition, core-biopsies were harvested using a trephine bur with an 
inner diameter of 1.8mm. The biopsies were performed at a level of 3mm below 
the implant shoulder perpendicular to the long axis of the implant with a sink 
depth of 3mm (Figure 3). The cover screw was removed and replaced by a 
healing abutment. The mucoperiosteal flap was adjusted and sutured to fit 
around the neck of the healing abutment. If a buccal concavity was persisting at 
this time-point, a soft tissue grafting procedure (Seibert, 1983, Schneider et al., 
2011, Thoma et al., 2016) was performed and implants left submerged for 
another 2 months before performing abutment connection.  
 
 
Histologic preparation and analyses 
The biopsies were fixed in 4% buffered formalin for at least 48 hours. The 
specimens were then rinsed in running tap water and demineralized for 72 hours 
(USEDECALC BioSystems, Muttenz, Switzerland). After decalcification they were 
watered again for 1 hour and dehydrated in a graded series of increasing ethanol 
concentrations and thereafter infiltrated with xylol and paraffin in a vacuum 
infiltration tissue processor (Tissue-Tek VIP, Sakura-Finetek, Torrance, CA/USA). 
Specimens were then embedded in paraffin and cut into 2-5µm thickness using a 
paraffin-microtome (MICROM, Medite GmbH, Dietlikon, Switzerland). The 
specimens were dried with warm air (Wärmeschrank, Bittmann, Basel, 
Switzerland), de-paraffinized with xylol and stained with Haemalaun-Eosin 
(Robert Hooke 1665, Böhmer 1865). 
A qualitative analysis was performed with a light-microscope (Leica CTR6000, 
Leica, Wetzlar, Germany) at a magnification of x200. Pictures of each specimen 
were taken with a camera attached to the microscope (Leica DFC450, Leica, 
Wetzlar, Germany) for further analysis. All available sections were quantitatively 
assessed for different tissue components by applying standard histological 
morphometrical techniques (Weibel 1980; Gundersen et al. 1988). The different 
components (background, non-mineralized tissue, mineralized tissue and bone 
substitute material) and their respective amount calculated in % within a central 
region of interest. Measurements were carried out using an image analysis 
software (LAS V4.3, Leica, Wetzlar, Germany).  
 
Statistical evaluation and analysis 
Outcome measures 
The following primary and secondary outcome variables were analyzed: 
Primary: vertical defect fill (dehiscence defect at the buccal aspect of the 
implant) 
Secondary: horizontal thickness of the regenerated bone at the buccal aspect of 
the implant; defect depth, defect width and infrabony defect height; soft tissue 
condition (dehiscences); clinical parameters (PPD, PCR, BOP,KM), 
histomorphometric outcome measures (percentage of newly formed bone, 
remaining amount of bone substitute material, bone substitute to bone contact) 
 
Sample size calculation 
The sample size was calculated according to a previously performed study using 
similar primary and secondary endpoints (Jung et al., 2009). As the primary 
endpoint of this study was the vertical defect fill, it was planned to recruit a total 
number of 34 patients (17 per group). This would enable to detect a difference of 
1mm between the test and control group with a standard deviation of σ=1 and a 
significance level of α=0.05 with a power of 80%. 
Descriptive statistics were applied to the data. Statistical analysis of the most 
important questions was based on non-parametric tests because of small sample 
sizes. Significance were determined using the Wilcoxon Mann-Whitney U-test with 
SAS 9.4. The level of significance was set at P<0.0083 since 6 tests (hypotheses) 
were applied for the 6 primary questions (by Bonferroni correction). A p-value 
between 0.05 and 0.0083 may be considered as a borderline significance pointing 
on a possible difference. Mean and standard deviations are given in the following 
section. In the tables medians are reported which are analyzed by the 
nonparametric tests.  For analysis of possible confounders a robust mixed model 
approach (with the R Package pbkrtest) was applied to a part of the data. All the 
other tests were used as explorative investigations. 
Results 
Demographics 
Eligible patients were enrolled between March 2010 and January 2013. 55 
patients were initially screened. Finally, a total of 27 patients could be 
randomized for treatment and included in the study (14 female, 13 male). All 
patients were in good general health and had previously undergone 
comprehensive dental care. They were all followed up to 6 months after implant 
placement. Thirteen patients were randomized for group RES and 14 patients for 
group N-RES. Seven implants were placed in the mandible, whereas 21 implants 
were placed in the maxilla. The exact distribution of implant sites and locations is 
depicted in Table 1.  
The mean age was 51.85 years (standard deviation ±29.7). Six patients were 
light smokers (≤ 10cig/day) and three patients had a history of periodontitis.  
 
Defect dimensions at implant placement and at re-entry 
All data for defect width, defect depth and infrabony defect size are displayed in 
Table 2a. Results for defect width and depth were statistically significant or 
borderline for the time-point (p=0.0001/p=0.003) but did not show effect of 
group interaction in the more complex mixed model. 
The mean vertical defect height after implant placement measured 4.00mm 
(±2.07) in group RES and 2.36mm (± 2.09) in group N-RES. At 6 months, the 
mean remaining vertical defect height measured 0.77mm (± 0.85) (RES) and 
0.21mm (±0.80) (N-RES). Table 2b&c 
Differences between the two groups were statistically borderline significant at 
both time-points (p=0.044/p=0.021). Mean changes in vertical defect height 
from baseline to 6 months measured 3.41mm (±2.33) (RES) and 2.14mm 
(±2.06) (N-RES) (p=0.1069). Table 2b&c  
This amounted to a vertical defect resolution of 85% (RES) and 90.7% (N-RES). 
Seven sites (6 RES / 1 N-RES) demonstrated incomplete vertical regeneration, 
whilst one site in group RES even showed an increased vertical defect height at 
re-entry compared to baseline (after implant placement). 
The mean horizontal thickness at the level of the implant shoulder measured 
3.46mm (± 0.52) (RES) and 2.82mm (± 0.50) (N-RES) following grafting with 
DBBM (p=0.0040). At 6 months, the mean horizontal thickness was 1.32mm (± 
1.38) (RES) and 2.68mm (± 1.05) (N-RES) (p=0.0167). Both groups showed a 
loss of horizontal thickness over time with a mean of 2.23mm  (±1.21) (RES) 
and 0.14mm (±0.79) (N-RES). The differences between the groups were 
statistically significant (p=0.0001) See Table 2b&c. 
 
Soft tissue condition 
Although primary wound closure was obtained in all patients, a total of six 
dehiscences (local adverse event) were observed during the 6-month follow-up. 
Four dehiscences were observed in group RES (30%) and two in group N-RES 
(14%). Five dehiscences were present at the time of suture removal. Four of 
these occurred in the RES group and healed spontaneously until the 4-week 
follow-up. One dehiscence in the N-RES group healed between the 4-week and 3-
month follow-up. The second dehiscence in the N-RES group occurred between 
suture removal and the 4-week follow-up. This patient was advised to apply local 
disinfecting agents (Plak Out Gel, Kerr Hawe SA, Bioggio, Switzerland and 
Solcoseryl, Meda Pharma GmbH, Wangen-Brüttisellen, Switzerland) and was 
recalled once a week for four weeks and later on once a month. The dehiscence 
persisted until the re-entry surgery at 6 months. 
The number of dehiscences at the different time-points is displayed in Table 3a. 
The soft tissue condition at re-entry is displayed in Table 3b. Overall, in all but 
one patient, the soft tissues were rated “normal” at 3 and 6 months after implant 
surgery. 
 
 
 
 
 
Clinical parameters  
Probing Pocket Depth (PPD) 
Mean PPD values varied between 2.27mm (±0.45mm;mesially) and 2.38mm 
(±0.44mm;distally) in group RES and 2.34mm (±0.29mm;mes) and 2.50mm 
(±0.42mm;dis) in group N-RES. At 6 months PPD values measured 2.24mm 
(±0.32mm;mes) and 2.44mm (±0.47mm;dis) for the RES group and 2.36mm 
(±0.25mm;mes) and 2.42mm (±0.35mm;dis). Results were statistically not 
significant for neither mesial/distal aspect, nor between the groups and at the 
two time points (p>0.05). 
Plaque control record (PCR) 
Plaque indices at time-point before implant placement and at 6 months did not 
show to be statistically significant when compared over time. No statistically 
significant differences were measured between the two groups.  
Bleeding-on-probing (BOP) 
BOP values did not show to be statistically significant over time for mesial values, 
but decreased over time for the distal values. These were statistically borderline 
significant (p=0.04). 
Keratinized Tissue (KM)  
The width of keratinized tissue decreased between screening (prior to surgery) 
and 6 months from 4.1mm (SD 0.77;mesial) and 4.0mm (±0.43; distal) to 
3.4mm (±0.47;mesial) and 2.9mm (±0.26;distal) in group RES . The 
corresponding values for group N-RES were 4.3mm (±.04;mesial) and 4.2mm 
(±0.2;distal) pre-surgically and decreased to 3.8mm (±0.3;mesial) and 3.6mm 
(±0.3;distal) at 6 months. For both groups the differences over time were 
borderline statistically significant (P=0.03). 
 
 
 
 
 
 
 
 
 
 
Histologic assessment 
In general, the histologic samples revealed loose DBBM particles surrounded to a 
large extent by newly formed bone and embedded in a loose connective tissue. 
Remodeling of the DBBM particles had taken place and led to the formation of 
vacuoles with intimate bone formation along the bone substitute surface. (Fig.4) 
The density of the DBBM particles and the newly formed bone as well as the 
density of the connective tissue demonstrated great variation within the groups. 
The histomorphometric analysis showed a mean amount of newly formed bone of 
38.0% (±18.4%) (RES) and of 35.7% (±29.5%) (N-RES). The remaining amount 
of DBBM was 36.4% (±8.3%) (RES) and 45.2% (±11.9%) (N-RES) revealing a 
slightly better containment of the augmented bone substitute material in group 
N-RES. The overall mean amount of mineralized tissue was 73.0% (±19.9%) 
(RES) and 69.6% (±16.7%) (N-RES). The surface fraction of bone substitute to 
bone contact measured calculated bone to bone substitute contact was 46.4% 
(±25.3%) (RES) and 41.1% (±19.1%) (N-RES). The differences between the two 
groups were not statistically significantly different for any of the histological 
assessments (p>0.05). 
Discussion 
The results of the present RCT demonstrated that i) both GBR membranes were 
successful in regenerating bone on the buccal side of dental implants regarding 
vertical defect fill and increase in horizontal thickness; ii) the horizontal thickness 
decreased to a significantly greater amount over time in group RES compared to 
group N-RES; iii) wound dehiscences occurred at a rate of 30% (RES) and 14% 
(N-RES), but healed with one exception during 6 months and without the need for 
premature removal of the membrane; iv) the augmented DBBM underwent 
remodeling processes and promoted new bone formation. 
 
Augmentation of hard tissue simultaneous with implant placement is considered a 
routine procedure with successful short- and long-term results (Chiapasco and 
Zaniboni, 2009, Jung et al., 2013, Hammerle et al., 2002). This is demonstrated 
by survival rates of implants placed in regenerated bone being similar when 
compared to implants placed conventionally into sites without the need for bone 
augmentation (Hammerle et al., 2002, Donos et al., 2008). Differences between 
resorbable and non-resorbable membranes mainly exist in terms of a need for a 
second stage surgery (removal of a non-resorbable membrane), a reported 
higher rate of dehiscences (non-resorbable membranes) and a higher risk of a 
membrane collapse (resorbable membranes) (Zitzmann et al., 1997, Wiltfang et 
al., 1998, Moses et al., 2005). 
In the present study, peri-implant defect dimensions were re-assessed 6 months 
after GBR procedure. Defect height, width and depth were all significantly lower 
at the re-entry time-point compared to the day of implant placement with 
simultaneous GBR. This demonstrated a successful bone augmentation in both 
groups with mean changes over time (defect resolution) ranging between 
3.41mm (RES) and 2.14mm (N-RES) and a very minimal persisting defect height 
remaining at reentry (0.77mm (RES) and 0.21mm (N-RES)). The difference in 
decrease was statistically significant between the groups. This is supported by a 
clinical multicenter study reporting a significant decrease in surface exposure 
when non-resorbable membranes were used for the treatment of fenestration or 
dehiscence-type defects (Dahlin et al., 1995). The remaining defect heights after 
healing periods of 3-6 months measured 1.1mm (±2.3) after an initial defect 
height of 4.7mm (±3.0) and were therefore slightly greater compared to the 
present study. Data on resorbable collagen membranes used in studies with a 
similar design reported dehiscence-type defect resolution for the combination of 
DBBM plus collagen membrane of 96% (4.25mm from 4.5mm) (Jung et al. 2009) 
and 91% (5.4mm from 5.8mm) (Jung et al. 2003), whereas in the present study 
defect resolution amounted to 85% (RES) and 90% (N-RES) respectively. In 
contrast, in a previous comparative study mean percentages of bone fill of 92% 
for resorbable and 78% for non-resorbable membranes were reported favoring 
the use of resorbable collagen membranes. However, in that study the relatively 
high rate of membrane exposure with non-resorbable membranes often led to 
premature removal due to infection. This was interpreted as the main reason for 
the lower defect fill for this type of membrane. (Zitzmann et al., 1997). In the 
present study, even though dehiscences occurred, no membranes were removed 
prior to the 6-month re-entry time-point. In addition, dehiscences were not 
associated with greater residual defect heights. 
Apart from the defect resolution, which reflects how well a GBR procedure 
performed in a vertical dimension, the horizontal thickness, measured at baseline 
(following GBR) and at re-entry surgery, documents the stability of the 
augmented area. The GBR principle is based on a membrane, which serves as a 
tent to allow for bone regeneration underneath. This space-maintenance can be 
obtained using a form-stable membrane or a bone substitute material that 
stabilizes a non-form-stable membrane. Since in the present study the same 
bone substitute material was used in both groups, the effect of the membrane in 
terms of stability and containment of the augmented area could be assessed. The 
horizontal thickness at baseline was greater in group RES compared to group N-
RES. At re-entry, however, the horizontal thickness in group N-RES was greater. 
Whereas in both groups, a loss of horizontal thickness was observed, the loss in 
group N-RES was statistically significantly smaller. This demonstrates that the 
collagen membrane tended to collapse even though being supported by the bone 
substitute material. 
It has previously been reported that in order to avoid vertical bone loss over 
time, a minimal buccal bone dimension of 2mm is required (Spray et al., 2000, 
Botticelli et al., 2004). One might speculate that for a successful GBR 2mm of 
buccal bone should be obtained. Keeping in mind these data and the loss of 
volume that predominantly occurred with the resorbable membrane, a buccal 
over contouring at the day of surgery might be recommended. The long-term fate 
of augmented bone and the optimal amount of bone required for stable results 
remains unknown today. More recent data even suggest that in cases with 
missing buccal bone on the implant surface, the peri-implant soft tissues might 
compensate and provide clinically successful outcomes (Benic et al., 2012, 
Kuchler et al., 2015). 
In the present study the number of wound dehiscences was comparable to results 
reported in previous studies using the same membranes (Moses et al., 2005). 
Though more dehiscences occurred in group RES (30%) than in group N-RES 
(14%). This to some extent contradicts results from previous studies with rates 
for dehiscences ranging from 11% (Dahlin et al., 1995) to 20% for non-
resorbable membranes (Chiapasco and Zaniboni, 2009) compared to rates 
ranging between 5% (Chiapasco and Zaniboni, 2009) and 31% for resorbable 
membranes (Jung et al., 2009). Most studies however, observed more 
dehiscences with non-resorbable membranes compared to resorbable membranes 
(Moses et al., 2005, Zitzmann et al., 1997). Dehiscences of non-resorbable 
membranes may lead to early removal of the membrane resulting in impaired 
bone regeneration. In contrast to previously published data (Moses et al., 2005) 
dehiscences in the present study were not associated with obtained residual 
defect heights at 6 months. In addition, the two membranes in group N-RES that 
had a dehiscence, did not have to be removed prematurely. Due to the strict 
application of local desinfecting agents the respective sites could be prevented 
from bacterial colonization of the underlying membrane. Similarly, membranes in 
group RES with dehiscences healed without the need for further surgical 
intervention. One explanation that might be associated with the number of 
dehiscences could be the incision design and handling of the flap. 
(Dahlin et al., 1995). In the present study the incision design was standardized 
and did not depend on the randomization. Incisions were made paracrestal 
(palatally or lingually) in order not to compromise blood supply. Subperiosteal 
incisions were made to allow for a tension-free adaptation of the wound margins. 
Moreover, a factor certainly contributing to the low numbers of wound 
dehiscences is a strict maintenance program. All patients in this study were 
recalled regularly for a check-up at set time-points, reinstructed for oral hygiene 
and supported by a professional cleaning. This was reflected in PCR values being 
stable and BOP values even decreasing over time up to 6 months. Another 
explantation for the higher number of dehiscences within RES group might be the 
following. Being aware of having to prematurely remove non-resorbable 
membranes in case of bacterial colonization, one may have tried not to 
overcontour the augmentation. It could well be assumed that in order to 
compensate for the horizontal resorption the surgeons augmented the sites within 
RES group to a greater extent. This is maybe reflected by a higher amount in 
horizontal thickness after GBR of 3.46mm (RES) versus 2.82 (N-RES). 
Although clinical evidence clearly shows the successfull use of e-PTFE membranes 
for bone regeneration procedures, dehiscences do occur quite often and may 
compromise the surgical outcome (Zitzmann et al., 1997, Moses et al., 2005). A 
possible reason for the vulnerability of these membranes towards microbial 
invasion in case of early exposure might be their macroporosity allowing for 
bacterial colonization of the membrane and thus leading a subsequent infection. 
As an alternative to the use of e-PTFE, non-expanded, a dense 
polytetrafluoroethylene (n-PTFE) was proposed due to its inherent characteristics. 
Most of the available literature on the use of n-PTFE is based on pre-clinical 
studies. Clinical studies are limited to case series only. Clinical procedures having 
been investigated including ridge preservation techniques or the placement of 
immediate implants with concomittant GBR procedures. Whether or not n-PTFE 
membranes can be successfully used for GBR procedures remains to be proven.  
(Carbonell et al., 2014) 
Both membranes contained the augmented DBBM to a similar extent as 
demonstrated by small standard deviations in both groups. In terms of bone 
regeneration, great variability was observed between the different sites. The 
calculated area fractions of newly formed bone range between 4% and 63% 
(RES) and 11% and 98% (N-RES). This rather high heterogeneity in between the 
sites is mostly due to the fact that in some biopsies, the obtained tissues 
contained a very loose and only slightly mineralized structure with DBBM particles 
being surrounded by a loose connective tissue. Since biopsies were taken 
superficially at the buccal aspect, some of the GBR material might not have been 
completely integrated and might therefore explain these differences. This is in 
agreement with a previous clinical study comparing a hydrogel membrane to the 
same collagen membrane used in the present study (Jung et al., 2009). In that 
study, a similar re-entry surgery at 6 months was performed and revealed a 
quality of newly formed bone that ranged from very dense to more soft bone. 
Previous studies on peri-implant GBR with harvested biopsies reported similar 
clinical observations (Zitzmann et al., 1997, Jung et al., 2009). Histologic data 
from biopsies taken 6 months after augmentation surgery with DBBM plus 
collagen membrane reported newly formed bone between 23% (Zitzmann et al., 
2001b) and 30% (Jung et al., 2003) and 39% for DBBM plus non-resorbable 
membrane (Friedmann et al., 2002). The mean amounts of newly formed bone in 
the present study were slightly higher with 38% (RES) and 36% (N-RES) within a 
similar observation period. 
The outcomes of the study certainly need to be interpreted with caution. This is 
mainly due to an imbalance in terms of the initial defect dimension that differed 
significantly or were borderline after implant placement. Applying the more 
complex mixed model, however, no effect of group interaction was demonstrated. 
Moreover, the distribution of sites for the two groups was imbalanced. This short-
coming was due to the nature of the randomization process that took place 
immediately after implant placement. This might have impacted the outcomes at 
6 months. Interestingly, at 6 months, the differences were from a clinical point of 
view negligible (even though for some outcomes measures statistically 
significant). Overall, a high number of patients did not fullfill the inclusion criteria. 
This was due to the need for primary bone augmentation or a lack of dehiscence 
after implant placement. If a GBR was applied on the buccal side of the implant 
only for contour reasons, the patient was not included in the study. Furthermore, 
the production of the non-resorbable e-PTFE membranes was discontinued and 
they were not available for use after the inclusion of 27 patients. This 
unfortunately lead to the termination of the recruitment phase and thus did not 
allow including more patients in this RCT. Still, other non-resorbable membranes 
were put on the market and are available for clinical use today. Therefore, further 
follow-up examinations will be performed evaluating longer term outcomes and 
trying to answer the question whether or not bone regenerated using resorbable 
or non-resorbable membranes around dental implants can be maintained over 
time.  
 
 
 
Conclusions 
 Guided bone regeneration for buccal dehiscence and fenestration-type defects 
can be achieved using either membrane. This was demonstrated by a similar 
vertical defect resolution and a similar horizontal thickness at 6 months in both 
groups. As collagen membranes do not maintain space and thus tend to collapse, 
the decrease in horizontal thickness was significantly different in favor of the 
non-resorbable membrane group at 6 months. Wound dehiscences occurred at a 
relatively high frequency in both groups, but were not associated with residual 
vertical defect height at 6 months. Histologically, both membranes allowed for 
new bone formation and contained a similar amount of bone substitute material 
during 6 months. 
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Figure Legends 
Figure 1 
Clinical measurements performed during implant surgery and at re-entry (6 
months). 
Figure 2 
Treatment groups with respective membrane. Collagen membrane in resorbable 
group (RES) and ePTFE-membrane in non-resorbable group (N-RES). 
Figure 3 
Clinical picture of a site at the time of re-entry 6 months after implant placement 
and GBR. A trephine bur with an inner diameter of 1.8mm is used to harvest the 
biopsy at 3mm below the implant shoulder perpendicular to the long axis of the 
implant with a sink depth of 3mm. 
Figure 4 
Histological sample harvested with a trephine bur with the respective amounts of: 
1) bone substitute material (DBBM), 2) newly formed bone and 3) soft tissue. 
Table 1 
Distribution of implant sites and locations in both groups. 
Table 2a/b/c 
Bone defect dimensions and horizontal thickness in millimeters at surgery and 
after 6 months . Mean values, standard deviations and medians (p-value of the 
R-test  and Wilcoxon Mann-Whitney test 2b/c). 
Table 3a/b 
3a Number of soft tissue dehiscences at the different time points of assessment. 
3b Soft tissue condition at the 6-month re-entry 
(normal/red/swollen/dehiscence). 
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Table 1
Table 2a
Table 2b
upper jaw (RES/N-RES) lower jaw (RES/N-RES) total
central incisors 4 (2/2) 0 4
lateral incisors 8 (1/7) 0 8
premolars 9 (9/0) 6 (4/2) 15
total 21 6 27
At Surgery At Re-entry (6m)
RES N-RES RES N-RES p-value
Defect dimensions time group
Width 3.08 
(±0.18)
3.00
3.19 
(±0.33)
3.00
0.73 
(±0.33)
.00
0.23 
(±0.23)
.00
p=0.0001 p=0.36
Depth 0.92 
(±0.23)
1.00
1.00 
(±0.28)
.00
0.41 
(±0.28)
.00
0.23 
(±0.23)
.00
p=0.003 p=0.75
Infrabony 0.15 
(±0.15)
.00
1.00 
(±0.59)
.00
0.0 (±0.0)
.00
0.0 (±0.0)
.00 p=0.02
At Surgery
RES N-RES p-value
Vertical & Horizontal 
Dimensions
Vertical defect
median
4.00 (±2.07)
4.00
2.36 (±2.09)
2.50 p=0.0444
Horizontal thickness
median
3.46 (±0.52)
3.00
2.82 (±0.50)
3.00 p=0.0040
Table 2c
At Re-entry 
(6months)
RES N-RES p-value
Defect dimensions
Vertical defect
median
0.77 (±0.85)
1.00
0.21 (±0.80)
0.00 p=0.0213
Horizontal thickness
median
1.32 (±1.38)
1.00
2.68 (±1.05)
3.00 p=0.0167
Loss of vertical defect
median
3.41 (±2.33)
4.00
2.14 (±2.06)
2.00 p=0.1069
Loss of horizontal 
thickness
median
2.23 (±1.21)
3.00
0.14 (±0.79)
0.00 p=0.0001
Table 3a 
Table 3b
1 week 
(suture removal)
4 weeks 3 months At Re-entry 
(6 months)
RES 4 0 0 0
N-RES 1 2 1 1
normal (e.g. healthy) red/swollen dehiscence
RES 6 2 0
N-RES 7 5 1
percentage 50.5% 25.9% 7.7%
